[HTML][HTML] Genetic testing in neurodevelopmental disorders

JM Savatt, SM Myers - Frontiers in Pediatrics, 2021 - frontiersin.org
Neurodevelopmental disorders are the most prevalent chronic medical conditions
encountered in pediatric primary care. In addition to identifying appropriate descriptive …

The role of genetics in cardiovascular disease: arrhythmogenic cardiomyopathy

CA James, P Syrris, JP Van Tintelen… - European heart …, 2020 - academic.oup.com
Arrhythmogenic cardiomyopathy (ACM) is a heritable cardiomyopathy characterized by
frequent ventricular arrhythmias and progressive ventricular dysfunction. Risk of sudden …

[HTML][HTML] 2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest …

MK Stiles, AAM Wilde, DJ Abrams, MJ Ackerman… - Heart Rhythm, 2021 - Elsevier
This international multidisciplinary document intends to provide clinicians with evidence-
based practical patient-centered recommendations for evaluating patients and decedents …

Opportunistic genomic screening. Recommendations of the European society of human genetics

G de Wert, W Dondorp, A Clarke… - European Journal of …, 2021 - nature.com
If genome sequencing is performed in health care, in theory the opportunity arises to take a
further look at the data: opportunistic genomic screening (OGS). The European Society of …

From genetics to genomics: facing the liability implications in clinical care

G Marchant, M Barnes, JP Evans, B LeRoy… - Journal of Law …, 2020 - cambridge.org
Health care is transitioning from genetics to genomics, in which single-gene testing for
diagnosis is being replaced by multi-gene panels, genome-wide sequencing, and other …

[PDF][PDF] The responsibility to recontact research participants after reinterpretation of genetic and genomic research results

Y Bombard, KB Brothers, S Fitzgerald-Butt… - The American Journal of …, 2019 - cell.com
The evidence base supporting genetic and genomic sequence-variant interpretations is
continuously evolving. An inherent consequence is that a variant's clinical significance might …

Management of individuals with germline pathogenic/likely pathogenic variants in CHEK2: A clinical practice resource of the American College of Medical Genetics …

H Hanson, E Astiazaran-Symonds, LM Amendola… - Genetics in …, 2023 - Elsevier
Purpose Although the role of CHEK2 germline pathogenic variants in cancer predisposition
is well known, resources for managing CHEK2 heterozygotes in clinical practice are limited …

Is there a duty to reinterpret genetic data? The ethical dimensions

PS Appelbaum, E Parens, SM Berger, WK Chung… - Genetics in …, 2020 - nature.com
The evolving evidence base for the interpretation of variants identified in genetic and
genomic testing has presented the genetics community with the challenge of variant …

Analysis of VUS reporting, variant reinterpretation and recontact policies in clinical genomic sequencing consent forms

DF Vears, E Niemiec, HC Howard… - European Journal of …, 2018 - nature.com
There are several key unsolved issues relating to the clinical use of next generation
sequencing, such as: should laboratories report variants of uncertain significance (VUS) to …

[HTML][HTML] Variant classification changes over time in BRCA1 and BRCA2

C Mighton, GS Charames, M Wang, KR Zakoor… - Genetics in …, 2019 - Elsevier
Purpose To report BRCA1 and BRCA2 (BRCA1/2) variant reassessments and
reclassifications between 2012 and 2017 at the Advanced Molecular Diagnostics Laboratory …